Chrysalis BioTherapeutics Competitors and Similar CompaniesClear all
Chrysalis BioTherapeutics's competitors and similar companies include Atea Pharmaceuticals, Centivax and ExeVir Bio.
 Chrysalis BioTherapeutics ChrysalisBioTherapeutics is a biopharmaceutical company developing regenerative drugs. |  Atea Pharmaceuticals Atea Pharmaceuticals is a biopharmaceutical company specializing in oral direct-acting antiviral therapies. |  Centivax Centivax is a vaccine platform biotechnology company aiming to treat and eradicate rapidly mutating pathogens. |  ExeVir Bio ExeVir Bio is a company that harnesses a llama-derived antibody technology platform to generate antiviral therapies providing broad protection against coronaviruses. | |
Founding Date | Founding Date 2012 | Founding Date 2014 | Founding Date 2019 | Founding Date 2020 |
Type | Type Private | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations Galveston, US HQ | Locations Boston, US HQ Boston, US | Locations South San Francisco, US HQ | Locations Gent, BE HQ |
Employees | Employees 6 | Employees 552% decrease | Employees 274% increase | Employees 1611% decrease |
Funding | ||||
Latest funding round | Latest funding round $ 10.4m (over 5 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 23m (about 5 years ago) |
Total funding raised | Total funding raised $ 11m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 50m |
For sources of this data, please see the company profile
View Company Profiles
Atea Pharmaceuticals
HQ
Boston, US
Employees
55↓ 2% decrease
Atea Pharmaceuticals is a biopharmaceutical company specializing in oral direct-acting antiviral therapies.
View companyCentivax
HQ
South San Francisco, US
Employees
27↑ 4% increase
Centivax is a vaccine platform biotechnology company aiming to treat and eradicate rapidly mutating pathogens.
View companyExeVir Bio
HQ
Gent, BE
Employees
16↓ 11% decrease
ExeVir Bio is a company that harnesses a llama-derived antibody technology platform to generate antiviral therapies providing broad protection against coronaviruses.
View company